Home > Browse Research > Life Sciences > Pharmaceuticals > Therapeutic Area > Allergy/Immunology

Allergy/Immunology: market research reports

Allergy/Immunology market research reports and industry analysis

Cough and Cold Preparations Market in Croatia to 2014 (OTC Healthcare) 2/23/2011 \| published by: Datamonitor ... volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods. Scope Market,category and segment level information on value, volume, and expenditure & consumption, ... \| read more...	$350.00
Cough, Cold and Allergy (hay Fever) Remedies - Latvia 2/21/2011 \| published by: Euromonitor International ... to an unusually hot summer and sudden weather changes there was a high number of cases of colds and therefore a higher than expected demand for decongestants. Euromonitor International's Cough, Cold and Allergy (Hay Fever) ... \| read more...	$900.00
Cough, Cold and Allergy (hay Fever) Remedies - Estonia 2/21/2011 \| published by: Euromonitor International ... affordable products or not buying these remedies at all. In addition, the spread of cold-related illnesses in 2010 was slightly less evident than in the colder months of 2009. People were also choosing cheaper products ... \| read more...	$900.00
Cough, Cold and Allergy (hay Fever) Remedies - China 2/18/2011 \| published by: Euromonitor International ... are regarded as one of the most familiar and popular remedies for Chinese consumers, after many years’ successful consumer education. Compared with the quicker growth of sales in 2009, performance in 2010 was a return ... \| read more...	$900.00
Cough, Cold and Allergy (Hay Fever) Remedies - Russia 2/17/2011 \| published by: Euromonitor International ... for some players and created new opportunities for others who better managed to keep pace with the new regulations. For example, Novartis did not register prices for its nasal sprays Otrivin and Dlyanos (these drugs ... \| read more...	$900.00
Cough, Cold and Allergy (hay Fever) Remedies - USA 2/15/2011 \| published by: Euromonitor International ... psychoactive stimulants that have a high propensity for addiction and abuse. The US government recognised this danger and passed the Combat Methamphetamine Epidemic Act (2006), which restricted sales of PSE and regulated the storage and... ... \| read more...	$900.00
Cough, Cold and Allergy (hay Fever) Remedies - Brazil 2/11/2011 \| published by: Euromonitor International ... Low unemployment rates and rising disposable income, in particular among lower-income families, contributed to a greater proportion of the Brazilian population gaining access to medicines. Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in ... \| read more...	$900.00
Gluten-Free Foods and Beverages in the U.S., 3rd Edition 2/1/2011 \| published by: Packaged Facts ... for the tens of millions of Americans who have reduced or eliminated their consumption of wheat, barley, rye, and oats. Indeed, consumer demand has driven the extraordinary surge in the market for gluten-free foods and ... \| read more...	$2,970.00
The Market for Rx to OTC Switches, 5th Editiion 2/1/2011 \| published by: Kalorama Information ... to over-the-counter status where possible. In the early part of the last decade there was a decline in Rx-to-OTC switches; since 2006, however, there has been a number of uses of this tactic to extend ... \| read more...	$3,500.00
The 2011-2016 World Outlook for Cough and Cold Remedies 1/20/2011 \| published by: Icon Group International, Inc. ... country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... \| read more...	$795.00
The 2011-2016 World Outlook for Cough, Cold, and Allergy Remedies 1/20/2011 \| published by: Icon Group International, Inc. ... the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. ... \| read more...	$795.00
The 2011-2016 World Outlook for Non-Prescription Beta Agonist Cough and Cold Preparations 1/20/2011 \| published by: Icon Group International, Inc. ... (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country ... \| read more...	$795.00
The 2011-2016 World Outlook for Prescription Narcotic Cough Preparations and Expectorants 1/20/2011 \| published by: Icon Group International, Inc. ... for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... \| read more...	$795.00
The 2011-2016 World Outlook for Prescription Non-Narcotic Cough Preparations and Expectorants 1/20/2011 \| published by: Icon Group International, Inc. ... for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... \| read more...	$795.00
The 2011-2016 World Outlook for Non-Prescription Decongestant Nasal Sprays 1/20/2011 \| published by: Icon Group International, Inc. ... country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... \| read more...	$795.00
The 2011-2016 World Outlook for Non-Prescription Decongestant Nose Drops 1/20/2011 \| published by: Icon Group International, Inc. ... country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... \| read more...	$795.00
The 2011-2016 World Outlook for Non-Prescription Cough and Cold Lozenges 1/20/2011 \| published by: Icon Group International, Inc. ... the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. ... \| read more...	$795.00
The 2011-2016 World Outlook for Non-Prescription Cough Syrups 1/20/2011 \| published by: Icon Group International, Inc. ... in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... \| read more...	$795.00
The 2011-2016 World Outlook for Non-Prescription Decongestants Excluding Nasal Sprays and Nose Drops 1/20/2011 \| published by: Icon Group International, Inc. ... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... \| read more...	$795.00
Allergy Therapy Pipeline Report 1/6/2011 \| published by: Life Science Analytics (LSA) ... and by stage as well as a summary of the latest news and developments in this area. Scope of the report: Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail ... \| read more...	$1,495.00
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, Q4, 2010 12/30/2010 \| published by: GlobalData ... information and data relating to the clinical trials on COPD. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the ... \| read more...	$1,000.00
Sinusitis - Pipeline Review, Q4 2010 12/27/2010 \| published by: Global Markets Direct ... latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sinusitis. “Sinusitis-Pipeline Review 2010, Q4 2010” is built using data and information sourced from ... \| read more...	$500.00
Forecast Revisit 2010-2011 Consumer Health 12/22/2010 \| published by: Euromonitor International ... emerged via regional and local corporate expansion, retailing development, and low-priced options. Consumers take control of their health as public health education improves, and this will help define the future of the industry. Euromonitor International’s ... \| read more...	$2,000.00
Allergic Rhinitis Market Forecast 12/10/2010 \| published by: Datamonitor ... classes having differing vulnerability to generic erosion. While the symptomatic treatment sales will decrease, immunotherapy sales are on the rise, with changing regulations dictating development. Reasons to Purchase Understand allergic rhinitis market trends, including life ... \| read more...	$15,200.00
Allergic Rhinitis - Pipeline Review, Q4 2010 12/8/2010 \| published by: Global Markets Direct ... Allergic Rhinitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Allergic Rhinitis. “Allergic Rhinitis-Pipeline Review 2010, Q4 2010” is built ... \| read more...	$500.00

< prev 7 8 9 10 11 12 13 14 15 16 next >